ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array

Yang, Junzheng; He, Qi; Wang, Yunhan; Pan, Zhaofeng; Zhang, Gangyu; Liang, Jianming; Su, Lijun; Wang, Ailin; Zeng, Chuning; Luo, Haoran; Liu, Lingyun; Li, Jianliang; Rao, Qiuhong; Wang, Baohua*; Wang, Haibin*; Chen, Peng*广州中医药大学; 1
PHYTOMEDICINE2022-1DOI: 10.1016/j.phymed.2021.153810
10被引21阅读
引用收藏
分享

摘要

Background: Osteoporosis affects more than half the patients with type 2 diabetes mellitus (T2DM). Up to data, there is no effective clinical practice in managing type 2 diabetes osteoporosis (T2DOP) because of its complex pathogenesis. Gegen Qinlian Decoction (GQD) has been used for the long-term management of T2DM. However, the underlying mechanism of GQD in the treatment of T2DOP remains unknown. @@@ Purpose: To reveal the role of GQD in T2DOP and its potential therapeutic targets in the management of T2DOP. @@@ Study Design: The effect of GQD on T2DOP was observed in db/db mice in four groups: model group, GQD lowdose group (GQD-L), GQD high-dose group (GQD-H), and metformin (positive control) group. C57BL/6J mice were used as the negative control group. @@@ Methods: Quantitative phytochemical analysis of GQD was performed using high-performance liquid chromatography (HPLC). Micro-CT and hematoxylin-eosin (H&E) staining were used to evaluate bone histomorphometry. To screen for candidate targets of GQD, a cytokine antibody array was used, followed by bioinformatics analysis. Quantitative real-time PCR (qRT-PCR) and western blotting (WB) were used to determine expression levels. @@@ Results: The major active components of GQD were confirmed by HPLC. Micro-CT and H&E staining showed that bone mass was significantly increased in the GQD-H group compared with the model group. Antibody arrays revealed that the expression of insulin-like growth factor binding protein 3 (IGFBP3) was elevated in the GQD-H group. The MAPK pathway was identified using bioinformatics analysis. Additionally, the levels of osteoclastogenesis-related genes, including cathepsin K (Ctsk), acid phosphatase 5 (Acp5), matrix metallopeptidase 9 (Mmp9), and ATPase H+ transporting VO subunit D2 (Atp6vOd2) were significantly decreased in the GQD-H group. Compared with the model group, high-dosage GQD inhibited phosphorylation of extracellular signal-regulated kinases (ERKs) and P38 mitogen-activated protein kinase (MAPK) and the expression of c-Fos and nuclear factor of activated T cells 1 (NFATc1). @@@ Conclusion: GQD plays a protective role in T2DOP by upregulating IGFBP3 expression and downregulating the IGFBP3/MAPK/NFATc1 signaling pathway. IGFBP3 in serum may also be a novel biomarker in the treatment of T2DOP. Our current findings not only expand the application of GQD, but also provide a theoretical basis and guidance for T2DOP.

学科与关键词

关键词
Gegen qinlian decoctionType 2 diabetes osteoporosisIGFBP3/MAPK/NFATc1 signaling pathwayCytokine antibody array
相关
加载中…
  • Gegen Qinlian decoction ameliorates type 2 diabetic osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on Cytokine Antibody
    Yang, Junzheng; He, Qi; Pan, Zhaofeng; Chen, Peng
  • RETRACTED: Focal Microscopy Observe the Mechanism of Gegen Qinlian Decoction Treating Type 2 Diabetic Nephropathy in Nude Mice (Retracted Article)
    Zheng, Fei; Xu, Juan; Gu, Hao*Biomed Research International, 2022, 2022: 1636301.被引 1
  • Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation
    He, Qi; Yang, Junzheng; Chen, Weijian; Pan, Zhaofeng; Chen, Baihao; Zeng, Jiaxu; Zhang, Nenling; Lin, Yuewei; Chen, Chuyi; Xiao, Jiacong; Li, Miao; Li, Shaocong; Wang, Haibin*; Chen, Peng*BMC Complementary Medicine and Therapies, 2024, 24(1): 24.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-01
卷期
第 94 卷
页码
153810
DOI
10.1016/j.phymed.2021.153810
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81774339, 82074462]; Major research project of Guangzhou University of Chinese Medicine [XK2019012]; Guang-dong Science Province and Technology Program Project [2017A020213030]; Guangzhou Science and Technology Planning Project [201707010319]

作者

  • Y

    Yang, Junzheng (第一作者)

    1 · guangzhou univ chinese med

  • H

    He, Qi

    1 · guangzhou univ chinese med

查看全部 16 位作者收起作者
  • W

    Wang, Yunhan

    guangzhou univ chinese med

  • P

    Pan, Zhaofeng

    1 · guangzhou univ chinese med

  • Z

    Zhang, Gangyu

    1 · guangzhou univ chinese med

  • L

    Liang, Jianming

    guangzhou univ chinese med

  • S

    Su, Lijun

    1 · guangzhou univ chinese med

  • W

    Wang, Ailin

    2 · guangzhou univ chinese med

  • Z

    Zeng, Chuning

    1 · guangzhou univ chinese med

  • L

    Luo, Haoran

    1 · guangzhou univ chinese med

  • L

    Liu, Lingyun

    guangzhou univ chinese med

  • L

    Li, Jianliang

    1 · guangzhou univ chinese med

  • R

    Rao, Qiuhong

    1 · guangzhou univ chinese med

  • W

    Wang, Baohua (通讯)

    1 · guangzhou univ chinese med

  • W

    Wang, Haibin (通讯)

    1 · guangzhou univ chinese med

  • C

    Chen, Peng (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417